Stockscreener 앱 받기
112.21
0.02%
0.02
전일 마감가:
$112.19
열려 있는:
$112.19
하루 거래량:
6.99M
Relative Volume:
0.79
시가총액:
$195.12B
수익:
$44.33B
순이익/손실:
$6.48B
주가수익비율:
30.30
EPS:
3.7033
순현금흐름:
$6.92B
1주 성능:
-0.42%
1개월 성능:
-7.37%
6개월 성능:
-15.27%
1년 성능:
-15.74%
1일 변동 폭
$111.18
$112.64
1주일 범위
$111.18
$113.59
52주 변동 폭
$105.27
$140.84
애보트 래버러토리스 Stock (ABT) Company Profile
명칭
Abbott Laboratories
전화
(224) 667-6100
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Compare ABT vs SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
112.21 | 195.08B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
380.23 | 142.61B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
96.86 | 125.10B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
74.58 | 112.29B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
79.78 | 45.80B | 6.07B | 1.06B | 799.60M | 1.8527 |
애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-10 | 개시 | The Benchmark Company | Buy |
| 2025-07-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-06-16 | 개시 | Leerink Partners | Market Perform |
| 2024-10-08 | 개시 | Oppenheimer | Outperform |
| 2024-09-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-21 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 재확인 | Barclays | Overweight |
| 2023-04-20 | 재확인 | Bernstein | Outperform |
| 2023-04-20 | 재확인 | JP Morgan | Overweight |
| 2023-04-20 | 재확인 | Raymond James | Outperform |
| 2023-04-20 | 재확인 | UBS | Buy |
| 2023-04-20 | 재확인 | Wolfe Research | Underperform |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-10-26 | 개시 | Mizuho | Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-27 | 재확인 | Credit Suisse | Outperform |
| 2022-01-27 | 재확인 | Morgan Stanley | Overweight |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | UBS | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-27 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-01-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-06-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-02-07 | 재확인 | BofA/Merrill | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-11-30 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-01-30 | 재확인 | Citigroup | Neutral |
| 2018-01-25 | 재확인 | Stifel | Buy |
| 2018-01-25 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-19 | 재확인 | Stifel | Buy |
모두보기
애보트 래버러토리스 주식(ABT)의 최신 뉴스
Abbott Laboratories $ABT Shares Sold by Tredje AP fonden - MarketBeat
Siligmueller & Norvid Wealth Advisors LLC Purchases Shares of 11,538 Abbott Laboratories $ABT - MarketBeat
Raiffeisen Bank International AG Purchases 33,095 Shares of Abbott Laboratories $ABT - MarketBeat
China Universal Asset Management Co. Ltd. Sells 15,607 Shares of Abbott Laboratories $ABT - MarketBeat
Rep. Thomas H. Kean, Jr. Purchases Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Pay Less, Gain More: STE, RMD Top Abbott Laboratories Stock - Trefis
Decoding Abbott Laboratories (ABT): A Strategic SWOT Insight - GuruFocus
Abbott Laboratories (ABT) Announces Positive Results for Amulet 360 Left Atrial Appendage (LAA) Occlude - Finviz
Abbott Laboratories (ABT) Announces Board of Directors Restructu - GuruFocus
Exact Sciences shareholders approve merger with Abbott Laboratories - Investing.com
Exact Sciences stockholders approve acquisition by Abbott - marketscreener.com
Exact Sciences Shareholders Approve Merger with Abbott Laboratories - TipRanks
Abbott Laboratories Streamlines Governance With Smaller Board - TipRanks
Abbott (ABT) to Acquire Exact Sciences Following Stockholder App - GuruFocus
Exact Sciences Shareholders Approve Acquisition by Abbott Laboratories - marketscreener.com
ABBOTT LABORATORIES SEC 10-K Report - TradingView
Exact Sciences Stockholders Approve Acquisition by Abbott - Stock Titan
Thomas Kean Jr makes strategic moves in Abbott Laboratories and General Motors - Investing.com
Abbott Laboratories (ABT) Maintains Quarterly Dividend - GuruFocus
Abbott declares 63-cent quarterly dividend, 409th consecutive - Investing.com
Abbott Laboratories Declares Quarterly Cash Dividend, Payable on May 15, 2026 - marketscreener.com
Abbott Keeps Quarterly Dividend at $0.63 a Share, Payable May 15 to Holders of Record as of April 15 - marketscreener.com
Abbott declares quarterly dividend of 63 cents per share - marketscreener.com
Abbott declares 409th consecutive quarterly dividend - PR Newswire
Woodley Farra Manion Portfolio Management Inc. Has $61.18 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Stock Is Down 16% From Its 52-Week High. Here’s Where the Stock Could Go in 2026 - TIKR.com
BSX vs. ABT: Which MedTech Stock is the Better Investment Now? - TradingView
NewEdge Wealth LLC Has $6.20 Million Stake in Abbott Laboratories $ABT - MarketBeat
Weight Management Supplements Market Report 2026: A $15+ - GlobeNewswire
Abbott unit defends European protection for heart valve ‘cuff’ design - Life Sciences Intellectual Property Review
Pharma Giants Amgen & Abbott Labs Commit to Transition Away from Horseshoe Crab Blood in Biomedical Testing Following Shareholder Engagement - As You Sow
Hemenway Trust Co LLC Has $45.81 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories: The Quiet Healthcare Giant You’re Sleeping On - AD HOC NEWS
ABT.SW Abbott Laboratories CHF100.00 pre-market 19 Feb 2026: Oversold bounce - Meyka
BTIG Research Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price - MarketBeat
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
First National Bank of Omaha Makes New $19.85 Million Investment in Abbott Laboratories $ABT - MarketBeat
Axxcess Wealth Management LLC Has $18.75 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Bought by Ingalls & Snyder LLC - MarketBeat
3 Large-Cap Stocks with Solid Fundamentals - The Globe and Mail
How The Abbott Offer Is Rewriting The Story For Exact Sciences (EXAS) - Yahoo Finance
NEOS Investment Management LLC Acquires 72,502 Shares of Abbott Laboratories $ABT - MarketBeat
Merit Financial Group LLC Grows Holdings in Abbott Laboratories $ABT - MarketBeat
Skandinaviska Enskilda Banken AB publ Buys 190,255 Shares of Abbott Laboratories $ABT - MarketBeat
A Look At Abbott Laboratories (ABT) Valuation As Libre 3 Lawsuit Raises Product Safety Concerns - simplywall.st
Abbott class action claims glucose sensors sold with defect - Class Action Lawsuits
Southeast Asset Advisors LLC Acquires 9,600 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Purchased by Vanguard Group Inc. - MarketBeat
Pallas Capital Advisors LLC Reduces Stock Position in Abbott Laboratories $ABT - MarketBeat
Shell Asset Management Co. Trims Stock Position in Abbott Laboratories $ABT - MarketBeat
Fifth Third Bancorp Sells 10,616 Shares of Abbott Laboratories $ABT - MarketBeat
애보트 래버러토리스 (ABT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.03%
0.74%
자본화:
|
볼륨(24시간):